ஒருங்கிணைந்த குழாய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒருங்கிணைந்த குழாய். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒருங்கிணைந்த குழாய் Today - Breaking & Trending Today

Президент Ильхам Алиев: Южный газовый коридор является проектом энергетической безопасности

Президент Ильхам Алиев: Южный газовый коридор является проектом энергетической безопасности
news.day.az - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news.day.az Daily Mail and Mail on Sunday newspapers.

European Union , Guidelines European Unioni Azerbaijan Consultative , Board European Union Charles Michel , Member States European Union , President Ilham Aliev , President Azerbaijan Ilham Aliev , President Board European Union Charles Michel , European Market , Guidelines European Union , Azerbaijan Consultative , Integrated Pipeline , Because Azerbaijan , ஐரோப்பிய தொழிற்சங்கம் , ஐரோப்பிய சந்தை , ஒருங்கிணைந்த குழாய் , ஏனெனில் அஜர்பைஜான் ,

GW Pharma to Be Acquired for $220

February 3, 2021 at 8:08 am
Published by NCV Newswire
GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader
Adds high-growth commercial franchise to Neuroscience portfolio with Epidiolex®, the first and only FDA-approved prescription cannabidiol medicine and a potential near-term blockbuster
Enhanced product diversification of combined company expected to provide accelerated double-digit revenue growth
Anticipated to be accretive in first full year of combined operations and substantially accretive thereafter
Conference call today at 8:30 AM ET
DUBLIN and LONDON, Feb. 3, 2021 /PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered into a definitive agreement for Jazz to acquire GW for $220.00 per American Depositary Share (ADS), in the form of $200.00 in cash and $20.00 in Jazz ordinary shares, for a total considerat ....

United States , United Kingdom , City Of , Rosen Katz , Jacqueline Kirby , Andrean Flynn , Ben Atwell , Bruce Cozadd , Scott Giacobello , Kristen Cardillo , Jazz Pharmaceuticals Investor Contact , Jp Morgan Securities , Jazz Pharmaceuticals , Gw Pharmaceuticals , Arthur Cox , European Union , Jazz Pharmaceuticals Media Contact , Gw Pharmaceuticals Media Contacts , Corporate Affairs Government Relations , Mission To Transform The Lives Of Patients , Drug Administration , Centerview Partners , Gw Pharmaceuticals Investor Contact , European Medicines Agency , Goldman Sachs Co , Swaine Moore ,

Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader

Share this article
Share this article
DUBLIN and LONDON, Feb. 3, 2021 /PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered into a definitive agreement for Jazz to acquire GW for $220.00 per American Depositary Share (ADS), in the form of $200.00 in cash and $20.00 in Jazz ordinary shares, for a total consideration of $7.2 billion, or $6.7 billion net of GW cash. The transaction, which has been unanimously approved by the Boards of Directors of both companies, is expected to close in the second quarter of 2021.
Upon close of the transaction, the combined company will be a leader in neuroscience with a global commercial and operational footprint well positioned to maximize the value of its diversified portfolio. ....

United Kingdom , United States , City Of , Rosen Katz , Jacqueline Kirby , Andrean Flynn , Ben Atwell , Epidiolex Epidyolex , Kristen Cardillo , Scott Giacobello , Bruce Cozadd , Jazz Pharmaceuticals Investor Contact , Jp Morgan Securities , Jazz Pharmaceuticals , Gw Pharmaceuticals , Arthur Cox , European Union , Jazz Pharmaceuticals Media Contact , Gw Pharmaceuticals Media Contacts , Corporate Affairs Government Relations , Mission To Transform The Lives Of Patients , Drug Administration , Centerview Partners , Gw Pharmaceuticals Investor Contact , Exchange Commission , European Medicines Agency ,